Sort
17,288 grants matching “multiple sclerosis”
Biomaterial-Based Delivery of Suppressor of Cytokine Signaling Mimetics to Ameliorate Type 1 Diabetes
$195,808Gregory Paul Marshall · Onevax, Llc · R43 · FY2018 · DK
Tracking the invaders in multiple sclerosis: Highly specific TREM1-targeted PET imaging of toxic infiltrating myeloid cells and early treatment response.
$195,781Michelle Louise James · Stanford University · R21 · FY2018 · NS
DETECTING THE TRANSFER OF MATERNAL ANTIBODIES INTO THE FETAL RHESUS MONKEY BRAIN
$195,729David G Amaral · University Of California At Davis · R21 · FY2016 · MH
Injectable Biomaterial Scaffold for Inducing Antigen-Specific Tolerance
$195,625Hao Cheng · Drexel University · R21 · FY2018 · AI
Nuclear export inhibition as a novel therapeutic target for C9ORF72 ALS/FTD
$195,625Christopher James Donnelly · University Of Pittsburgh At Pittsburgh · R21 · FY2018 · NS
Role of soluble TREM2 and its R47H and D87N variants in neurodegenerative disease
$195,625Steven G Younkin · Mayo Clinic Jacksonville · R21 · FY2015 · NS
Identification of a novel resistance gene for demyelinating disease
$195,625Elizabeth P. Blankenhorn · Drexel University · R21 · FY2018 · AI
Unraveling the role of the molecular co-chaperone DNAJC7 in protein homeostasis and neurodegeneration
$195,570Biswarathan Ramani · University Of California, San Francisco · K08 · FY2024 · NS
Unraveling the role of the molecular co-chaperone DNAJC7 in protein homeostasis and neurodegeneration
$195,570Biswarathan Ramani · University Of California, San Francisco · K08 · FY2025 · NS
Guidance of Oligodendrocyte Processes: The Role of Local Protein Synthesis
$195,563Babette Fuss · Virginia Commonwealth University · R21 · FY2007 · NS
HUMAN MONOCLONAL ANTIBODIES FOR CNS REGENERATION
$195,526Acorda Therapeutics, Inc. · R41 · FY2000 · NS
Selective modulation of thyroid hormone receptors to promote remyelination
$195,413Peter A Calabresi · Johns Hopkins University · R21 · FY2013 · NS
Imaging the Sphingosine-1-Phosphate Receptor 1 (S1P1)
$195,320Zhude Tu · Washington University · P41 · FY2022 · EB
Leveraging myelin-sensitive imaging to predict early lesion pathogenesis in cerebral adrenoleukodystrophy
$195,235Eric Mallack · Weill Medical Coll Of Cornell Univ · K23 · FY2022 · NS
Leukocyte trafficking through the choroid plexus as modulator of neonatal focal stroke
$195,200Zinaida Vexler · University Of California, San Francisco · R21 · FY2017 · NS
Directed differentiation of embryonic stem cells for urologic applications
$195,167James A Bassuk · Seattle Children'S Hospital · K18 · FY2010 · DK
HLA class II transgenic mice as experimental model of MS
$195,164Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2002 · NS
Immune recognition in a Picornavirus model of MS
$195,164Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2002 · NS
Transgenic expression of Theiler's Virus encoded regions
$195,164Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2001 · NS
HLA class II transgenic mice as experimental model of MS
$195,164Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2000 · NS
Immune recognition in a Picornavirus model of MS
$195,164Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2000 · NS
Immune recognition in a Picornavirus model of MS
$195,164Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2001 · NS
Transgenic expression of Theiler's Virus encoded regions
$195,164Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2002 · NS
Transgenic expression of Theiler's Virus encoded regions
$195,164Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2000 · NS
HLA class II transgenic mice as experimental model of MS
$195,164Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2001 · NS